Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial - Concepedia

Concepedia

Publication | Closed Access

Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial

91

Citations

22

References

2022

Year

Jens Y. Humrich, P. Cacoub, Michèlle Rosenzwajg, Fabien Pitoiset, Hang Phuong Pham, Joel Guidoux, David Leroux, Thomas Vazquez, Gabriela Riemekasten, Josef S Smolen,

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1